Posted by Quintal on January 26, 2007, at 1:10:01
In reply to Re: Wyeth gets approvable letter from FDA for Pris, posted by notfred on January 25, 2007, at 23:38:05
>Where does the NHS stand on cases such as this ?
British doctors seem to have a healthy scepticism of this type of patent extender. They will prescribe some of the new single-isomer meds such as escitalopram (Cipralex here in the UK) but they are generally reserved as second-line treatments mainly for treatment resistant patients and for people having unacceptable side effects on the racemic mixtures. In other words they're available to people who might really benefit from them, but they're not foisted upon patients as superior products unless the doctors see superior results from them, and they rarely do.
Q
poster:Quintal
thread:726403
URL: http://www.dr-bob.org/babble/20070125/msgs/726586.html